What is Instituto Rosenbusch Operating Cash Flow per Share?
Instituto Rosenbusch's operating cash flow per share for the
three
months ended in Dec. 2024 was ARS-1.57.
Instituto Rosenbusch's operating cash flow per share for the trailing twelve months (TTM) ended in Dec. 2024 was ARS12.86.
During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Instituto Rosenbusch was 65.20% per year.
During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 110.90% per year.
During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 82.30% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.
The historical rank and industry rank for Instituto Rosenbusch's Operating Cash Flow per Share or its related term are showing as below:
BUE:ROSE'
s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -76.7 Med: 44.85 Max: 342.3
Current: 110.9
During the past 13 years, Instituto Rosenbusch's highest 3-Year average Operating Cash Flow per Share Growth Rate was 342.30% per year. The lowest was -76.70% per year. And the median was 44.85% per year.
BUE:ROSE's 3-Year OCF Growth Rate is ranked better than 97.31% of 780
companies
in the Drug Manufacturers industry
Industry Median: 8.85
vs BUE:ROSE: 110.90
Instituto Rosenbusch Operating Cash Flow per Share Historical Data
The historical data trend for Instituto Rosenbusch's Operating Cash Flow per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Instituto Rosenbusch Operating Cash Flow per Share Chart
Competitive Comparison of Instituto Rosenbusch's Operating Cash Flow per Share
For the Drug Manufacturers - Specialty & Generic subindustry, Instituto Rosenbusch's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Instituto Rosenbusch's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Instituto Rosenbusch's Price-to-Operating-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Instituto Rosenbusch's Price-to-Operating-Cash-Flow falls into.
Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ARS12.86
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Instituto Rosenbusch Operating Cash Flow per Share Related Terms
Thank you for viewing the detailed overview of Instituto Rosenbusch's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.
Instituto Rosenbusch SA is a pharmaceutical company based in Argentina. The company is engaged in the processing and industrialization of biological, chemical, pharmaceutical products of any kind, nature or destination, preferably for veterinary use or intended to combat pests and diseases of the agricultural exploitation. The company has line of products such as Biologicals and pharmaceuticals. Biologicals offer Campy 3, Cultivac 6M and Bovine Antibrucelosis. Pharmaceuticals offer Diclosan A Intrammamary, Diclosan S Intrammamary and Mastilina V-S.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
BUE:ROSE has been successfully added to your 